{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/658e4b085b1cd50016929a67/65eea16055a1700016c02dfb?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"ICAHT Take It Anymore!","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/658e4b085b1cd50016929a67/1710137187775-7da7d2d535083da4cfdba225998909b8.jpeg?height=200","description":"<p>We're joined 'in the studio' by our very first interview guest, our good friend, the brilliant Dr. Kai Rejeski. Kai has been at the forefront of understanding hematologic toxicity of CAR-T therapies, and speaks with us about the HEMATOTOX score, ICAHT guidelines, and the excellent coffee in San Antonio.</p>","author_name":"Mohammad Alhomoud and Joshua Fein"}